FordDirect and Cox Automotive’s VinSolutions Strengthen Their Partnership with Smart VINCENT Integration

— Ford Dealers and Lincoln Retailers will save time in customer, vehicle and incentives searches with Smart VINCENT. — Sales and transaction processes are streamlined with improved customer relationship management. — The Smart VINCENT integration marks the fifth innovation between VinSolutions and FordDirect since 2024 and will be showcased at the NADA Show 2025. VinSolutions, […]

Tiny Health Launches Index Predicting Child’s Gut Microbiome Age

AUSTIN, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) — Tiny Health, a leader in at-home gut microbiome testing, today announced the launch of its Gut Maturation Index, an advanced machine learning tool that predicts a child's gut microbiome age with 1-2 month accuracy up to age three. This innovative tool enables parents to compare their child's

NEWTON GOLF to Present at the DealFlow Events MicroCap Conference

(NASDAQ:SPGC), CAMARILLO, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) — NEWTON GOLF Company (Nasdaq: SPGC) (“NEWTON GOLF” or the “Company”), a technology-forward golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other golf-related accessories, announces that Greg Campbell, Executive Chairman, will present a corporate overview at the DealFlow Events

Improving health outcomes for communities in Saint John, New Brunswick

The illegal toxic drug supply and overdose crisis is having tragic impacts on communities throughout Canada. Our family, friends and neighbours have been impacted by this tragic public health crisis. Canada's approach is focused on providing access to a full continuum of health care services and leveraging tools at our disposal to save lives, connect

Revelation Pharma Strengthens Its Nationwide Presence in ENT and Animal Health with Acquisition of Cascade Specialty Pharmacy

Addition expands national network of compounding pharmacies in the west and northwest, including California Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies, today announced its acquisition of Washington-based Cascade Specialty Pharmacy. Cascade Specialty Pharmacy brings a robust legacy of excellence in ENT and Animal Health compounding to Revelation Pharma's growing portfolio.

Say Goodbye to Boring Interiors – Hernest’s Latest Designs Are Here to Dazzle

Hernest is delighted to introduce its exclusive new collection, a testament to the brand's distinctive approach to modern furniture design. This carefully curated series features five exceptional pieces, each thoughtfully crafted to elevate the aesthetics and functionality of any space, from cozy living rooms to elegant dining areas. With a focus on timeless design and

AvaWatz Combines AI Innovation with Everyday Safety in New Investment Opportunity

AvaWatz Company (“AvaWatz”), a trusted partner of U.S. Defense and Homeland Security and a leader in AI-driven autonomous systems is excited to announce the launch of a new equity crowdfunding campaign on Wefunder – https://wefunder.com/avawatz. Building on its mission-critical technologies and commercial successes, AvaWatz invites early supporters and new investors to join this groundbreaking opportunity

Q4 Appoints Jake Wolff as Chief Revenue Officer

Wolff's Successes Scaling Global Companies will Further Q4's Strategic Growth as the Company Extends its Leadership in IR Ops Software – Helping More Businesses Elevate Investor Relations with AI Q4 Inc., the leading provider of IR Ops software, today announced the appointment of Jake Wolff as chief revenue officer (CRO). In his role, Wolff will

Equativ Unveils Maestro by Equativ: Its Most Advanced End-to-End Curation Platform for Enhanced Campaign Performance and Greater Control for Advertisers

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Equativ, a global independent adtech company, today announced major upgrades to its all-in-one curation platform, Equativ Buyer Connect (EBC), now renamed Maestro by Equativ, that centralizes programmatic campaign management and provides ad buyers with direct access to high-quality, scaled supply. Since launching its curation platform four years

Artax Biopharma achieves clinical validation of first-in-class, oral, Nck modulator AX-158 for autoimmune disease in phase 2a study

Novel breakthrough: first molecule to modulate the fundamental mechanism ofT cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI improvements in Phase 2a in patients with psoriasis Phase 2a confirms well-tolerated safety profile, with no infections or discontinuations Artax Biopharma, Inc., a clinical-stage biotechnologycompany focused on

Scroll to Top